Director/PDMR Shareholding

RNS Number : 2823I
Hansa Investment Company Limited
31 March 2020
 

 

Director/PDMR Shareholding

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

On 30 March 2020, Hansa Investment Company Limited (the "Company") was notified that Jonathan Davie, Director of the Company, had switched an interest in the share capital of the Company shares from a share account into a SIPP. Following this switch, his total interest in the Company is 45,000 ordinary shares and 230,000 'A' ordinary shares.

This notification is made in accordance with the requirements of the Market Abuse Regulation.

Notification of dealing form

1. Details of the person discharging managerial responsibilities/persons closely associated

1. 

Name of natural person

First Name(s): 

Last Name(s):

Legal person

 

Jonathan

Davie

Pershing Nominees Ltd

2. Reason for the notification

2. 

Position/status

 

Jonathan Davie is Director of Hansa Investment Company Limited

3. 

Initial notification/amendment

Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

4. 

Full name of the entity

Hansa Investment Company Limited

5. 

Legal Entity Identifier code

213800RS2PWJXSZQDF66

4. Details of the transaction(s)

6. 

Description of the financial instrument, type of instrument*

'A' Ordinary shares of 1 pence each
Ordinary shares of 1 pence

7. 

Identification Code

BMG428941089 ('A' Ordinary Shares)
BMG428941162 (Ordinary Shares)

8. 

Nature of the transaction

Reorganisation of holding in Hansa Investment Company Limited (transfer from a share account into a SIPP)

9. 

Currency

GBP

10. 

Price(s) and Volumes(s)

Sold

'A' Ordinary Shares
Price: £1.34
Volume: 30,000

Ordinary Shares
Price: £1.295
Volume: 20,000

11. 

Date of transaction

30 March 2020

12. 

Place of transaction

Outside of a trading venue

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHZFLFXBXLZBBZ
Investor Meets Company
UK 100